Vadakke Puthiyottil, S., Edayattil, A., & N K, S. (2026). Pathologic Response to Neoadjuvant Subcutaneous Fixed-Dose Pertuzumab–Trastuzumab (Phesgo®) and Chemotherapy in HER2-Positive Locally Advanced Breast Cancer: A Case Series and Literature Review. Asian Pacific Journal of Cancer Care, 11(3), 481-488. https://doi.org/10.31557/apjcc.2026.11.3.481-488